Pharmaceutical

Boehringer Ingelheim offers Humira biosimilar at 92% discount

Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for $550 in a two- pack form.

Jul 20, 2024 - 04:00
Boehringer Ingelheim offers Humira biosimilar at 92% discount
Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for $550 in a two- pack form.
Read the original article

Tags:

Previous Article

Tech leader’s $125m boosts Parker Institutes immunotherapy research

Next Article

Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

EMA supports Sandoz’s Tysabri biosimilar amid various endorsements

EMA supports Sandoz’s Tysabri biosimilar amid various e...

Jul 25, 2023

Emergency medicine is grappling with a surprising problem: The prospect of too many physicians

Emergency medicine is grappling with a surprising probl...

Oct 28, 2023

Opinion: Hospices can’t handle the growing number of patients who need wound care

Opinion: Hospices can’t handle the growing number of pa...

Nov 25, 2023